Strategic Expansion Nusano is rapidly expanding its West Valley City production campus with a major new facility in Salt Lake City, signaling growing demand for medical and industrial isotopes and creating multiple cross-selling opportunities for ancillary services, supply chain optimization, and industrial partnerships.

Public Sector Uptake Recent DoE engagement under the Nuclear Energy Launch Pad program indicates government backing and potential for large-scale, long-term contracts in nuclear medicine and isotope supply, suggesting partnerships with government agencies, contractors, and research institutions.

Stable Supply Advantage Nusano emphasizes supply stability and reliable access to high-quality radioisotopes, a compelling value proposition for hospitals, cancer centers, and radiopharmacy networks facing treatment delays, enabling targeted outreach to healthcare providers and radiopharma distributors.

Recognition & Leadership Awards for Innovation and Best Places to Work, plus a female leadership recognition, bolster brand credibility and can be leveraged to open conversations with potential customers, partners, and talent-focused investors in the biotech and healthcare sectors.

Tech & Ops Readiness With a tech stack including Kubernetes, MongoDB, and modern CI/CD practices, Nusano demonstrates robust operational capabilities that can be cross-sold as scalable data/analytics, supply chain visibility, and digital partnering platforms to manufacturing, logistics, and healthcare clients.